We are exploring how Tezepelumab may improve airway barrier function in patients with severe asthma, including those with chronic rhinosinusitis. This study looks at the effects of the treatment on the airways' response to harmful substances.
Health conditions and diseases that the clinical trial is designed to study and treat.
Severe asthma with chronic rhinosinusitis and nasal polyps is a condition where asthma symptoms are exacerbated by inflammation in the nasal passages, leading to the formation of polyps, which can cause difficulty breathing and sinus issues.
Severe asthma without chronic rhinosinusitis is a serious form of asthma characterized by frequent and intense symptoms that can significantly impact daily life, but without the complications of chronic sinus inflammation.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.